叉头盒Q1是乳腺癌细胞中自的新型调节剂
相关实验视频
Updated: Jul 28, 2025

07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
570
Su-Hyeong Kim1, Eun-Ryeong Hahm1, Shivendra V Singh1,2
1Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Molecular carcinogenesis
|June 2, 2023
概括
叉头盒Q1 (FoxQ1) 转录因子促进乳腺癌细胞的自. 这种新功能表明,FoxQ1对细胞亡起着保护作用,影响癌症的进展.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 叉头盒Q1 (FoxQ1) 是一种在人类乳腺癌中过度表达的转录因子.
- 众所周知,FoxQ1促进乳腺癌类干细胞和上皮细胞转化为介质细胞.
研究的目的:
- 为了研究FoxQ1在乳腺癌细胞中的新功能.
- 确定FoxQ1在自调节中的作用及其对亡的影响.
主要方法:
- 在SUM159和MCF-7乳腺癌细胞系中过度表达FoxQ1.
- 对自标记物的分析 (LC3B-I/II转换,LC3B点,传输电子显微镜).
- 基因表达概况,西部斑点和染色体免疫沉试验.
- 自的药理抑制 (ATG4B) 和诱导亡的评估.
主要成果:
- 过度表达FoxQ1增加了自标志物 (LC3B-I转换为LC3B-II).
- FoxQ1调节了与自相关的基因的表达 (例如,上调的ATG4B,CXCR4;下调的BCL2L1,DRAM1).
- 福克斯Q1直接与ATG4B促进体结合,并赋予了对亡的抵抗力.
结论:
- FoxQ1被确定为乳腺癌细胞中自的新型调节者.
- 福克斯Q1对亡起着保护作用,可能通过自调节.
- 这些发现突出了FoxQ1作为乳腺癌治疗中的潜在治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Autophagy
4.4K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

